首页> 外文期刊>Antimicrobial Resistance and Infection Control >Correlation between biofilm formation and resistance toward different commonly used antibiotics along with extended spectrum beta lactamase production in uropathogenic Escherichia coli isolated from the patients suspected of urinary tract infections visiting Shree Birendra Hospital, Chhauni, Kathmandu, Nepal
【24h】

Correlation between biofilm formation and resistance toward different commonly used antibiotics along with extended spectrum beta lactamase production in uropathogenic Escherichia coli isolated from the patients suspected of urinary tract infections visiting Shree Birendra Hospital, Chhauni, Kathmandu, Nepal

机译:从疑似尿路感染患者中分离出来的尿路致病性大肠杆菌中,生物膜形成与对不同常用抗生素的耐药性以及广谱β-内酰胺酶产生之间的相关性,这些患者前往尼泊尔加德满都Chhauni的Shree Birendra医院就诊。

获取原文
       

摘要

Escherichia coli is the most predominant causative agent of urinary tract infection (UTI). Recently, increase in drug resistance among the uropathogenic bacteria has caused great problem in treatment of UTI. The main objective of this research is to determine the correlation between biofilm formation and resistance toward different commonly used antibiotics along with extended spectrum beta lactamase production in uropathogenic Escherichia coli. The urine samples collected from the patients suspected of urinary tract infections (visiting Shree Birendra Hospital, Chhauni, Kathmandu, Nepal between July to December 2013) were cultured in cystine lactose electrolyte deficient (CLED) agar by using semi quantitative culture technique. Extended spectrum beta lactamase (ESBL) production was detected by combined disc diffusion technique and biofilm formation was detected by Congo red agar method. Chi-square test was applied and p-value?
机译:大肠杆菌是尿路感染(UTI)的最主要病原体。近来,尿路致病细菌之间的耐药性增加已引起治疗UTI的巨大问题。这项研究的主要目的是确定尿液致病性大肠杆菌中生物膜形成与对不同常用抗生素的耐药性以及广谱β-内酰胺酶产生之间的相关性。使用半定量培养技术在怀疑胱氨酸乳糖缺乏电解质(CLED)的琼脂中培养从疑似尿路感染患者(2013年7月至12月访问尼泊尔加德满都Chhauni的Shree Birendra医院)收集的尿液样品。结合碟片扩散技术检测超广谱β内酰胺酶(ESBL)的产生,刚果红琼脂法检测生物膜的形成。应用卡方检验,并且p值≤0.05被认为具有统计学意义。从1480份尿液样本中,从208份(14.1%)样本中分离出大肠杆菌。在产生ESBL的大肠埃希菌的69株(占33.2%)中,有20株(占29%)是强生物膜生产者,有22株(占31.9%)是中度生物膜生产者,有11株(占15.9%)是弱生物膜生产者。非生物膜生产者为16(23.2%)。在139个ESBL非生产性大肠杆菌中,有22个(15.8%)是强生物膜生产商,有20个(14.4%)是中度生物膜生产商,有13个(9.4%)是弱生物膜生产商,有84个(60.4%)。生物膜非生产者。在总共108个产生生物膜的大肠杆菌中,观察到对头孢氨苄的最大耐药性,其次是阿莫西林,对阿米卡星的敏感性最高。发现产生ESBL的大肠杆菌中生物膜形成的能力明显高于不产生ESBL的菌株中的生物膜形成能力(p << 0.05)。在产生生物膜的大肠杆菌中,与未产生生物膜的菌株相比,其对抗菌剂的耐药率更高。根据我们对大肠杆菌的耐药性模式,为了开始在尼泊尔进行尿路感染的初步治疗,我们建议使用丁胺卡那霉素或呋喃妥因。此外,对于尿路感染的治疗,应根据尿培养和敏感性报告选择抗生素。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号